RxSight, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
RxSight, Inc. (RXST) reported Revenue from Contract with Customer, Excluding Assessed Tax of $27.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-05
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $27.24M, a 19.01% decline year-over-year.
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $30.89M, a 18.48% decline year-over-year.
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $32.61M, a 18.91% decline year-over-year.
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $30.34M, a 14.09% decline year-over-year.
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $134.48M, a 3.89% decline from fiscal 2024.
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $139.93M, a 57.09% increase from fiscal 2023.
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $89.08M, a 81.77% increase from fiscal 2022.
- RxSight, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $49.01M, a 116.90% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.24M 10-Q · filed 2026-08-05 | $58.13M 10-Q · filed 2026-08-05 | $90.74M derived: sum of 3 quarters · filed 2026-08-05 | $121.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $30.89M 10-Q · filed 2026-05-06 | $63.50M derived: sum of 2 quarters · filed 2026-05-06 | $93.84M derived: sum of 3 quarters · filed 2026-05-06 | $127.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $32.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $62.95M derived: sum of 2 quarters · filed 2026-02-25 | $96.58M derived: sum of 3 quarters · filed 2026-08-05 | $134.48M 10-K · filed 2026-02-25 |
| 2025-09-30 | $30.34M 10-Q · filed 2025-11-05 | $63.98M derived: sum of 2 quarters · filed 2026-08-05 | $101.87M 10-Q · filed 2025-11-05 | $142.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $33.64M 10-Q · filed 2026-08-05 | $71.53M 10-Q · filed 2026-08-05 | $111.75M derived: sum of 3 quarters · filed 2026-08-05 | $147.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $37.90M 10-Q · filed 2026-05-06 | $78.11M derived: sum of 2 quarters · filed 2026-05-06 | $113.42M derived: sum of 3 quarters · filed 2026-05-06 | $148.31M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $40.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $75.53M derived: sum of 2 quarters · filed 2026-02-25 | $110.42M derived: sum of 3 quarters · filed 2026-02-25 | $139.93M 10-K · filed 2026-02-25 |
| 2024-09-30 | $35.31M 10-Q · filed 2025-11-05 | $70.20M derived: sum of 2 quarters · filed 2025-11-05 | $99.71M 10-Q · filed 2025-11-05 | $128.29M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $34.89M 10-Q · filed 2025-08-07 | $64.40M 10-Q · filed 2025-08-07 | $92.98M derived: sum of 3 quarters · filed 2026-02-25 | $115.18M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $29.51M 10-Q · filed 2025-05-07 | $58.09M derived: sum of 2 quarters · filed 2026-02-25 | $80.29M derived: sum of 3 quarters · filed 2026-02-25 | $101.10M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $28.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $50.78M derived: sum of 2 quarters · filed 2026-02-25 | $71.59M derived: sum of 3 quarters · filed 2026-02-25 | $89.08M 10-K · filed 2026-02-25 |
| 2023-09-30 | $22.20M 10-Q · filed 2024-11-07 | $43.01M derived: sum of 2 quarters · filed 2024-11-07 | $60.50M 10-Q · filed 2024-11-07 | $76.59M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $20.81M 10-Q · filed 2024-08-05 | $38.30M 10-Q · filed 2024-08-05 | $54.39M derived: sum of 3 quarters · filed 2025-02-25 | $67.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $17.49M 10-Q · filed 2024-05-06 | $33.58M derived: sum of 2 quarters · filed 2025-02-25 | $46.19M derived: sum of 3 quarters · filed 2025-02-25 | $57.55M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $16.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $28.70M derived: sum of 2 quarters · filed 2025-02-25 | $40.06M derived: sum of 3 quarters · filed 2025-02-25 | $49.01M 10-K · filed 2025-02-25 |
| 2022-09-30 | $12.62M 10-Q · filed 2023-11-09 | $23.98M derived: sum of 2 quarters · filed 2023-11-09 | $32.92M 10-Q · filed 2023-11-09 | $41.34M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $11.36M 10-Q · filed 2023-08-07 | $20.30M 10-Q · filed 2023-08-07 | $28.73M derived: sum of 3 quarters · filed 2023-08-07 | $34.51M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $8.94M 10-Q · filed 2023-05-09 | $17.37M derived: sum of 2 quarters · filed 2023-05-09 | $23.15M derived: sum of 3 quarters · filed 2023-05-09 | $28.05M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $14.21M derived: sum of 2 quarters · filed 2023-03-06 | $19.11M derived: sum of 3 quarters · filed 2023-03-06 | $22.59M 10-K · filed 2023-03-06 |
| 2021-09-30 | $5.79M 10-Q · filed 2022-11-07 | $10.68M derived: sum of 2 quarters · filed 2022-11-07 | $14.17M 10-Q · filed 2022-11-07 | $19.08M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $4.90M 10-Q · filed 2022-08-08 | $8.38M 10-Q · filed 2022-08-08 | $13.29M derived: sum of 3 quarters · filed 2022-08-08 | $17.46M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $3.48M 10-Q · filed 2022-05-05 | $8.40M derived: sum of 2 quarters · filed 2022-05-05 | $12.57M derived: sum of 3 quarters · filed 2022-05-05 | $15.27M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $9.08M derived: sum of 2 quarters · filed 2022-03-08 | $11.79M derived: sum of 3 quarters · filed 2022-03-08 | $14.68M 10-K · filed 2022-03-08 |
| 2020-09-30 | $4.17M 10-Q · filed 2021-11-10 | $6.88M derived: sum of 2 quarters · filed 2021-11-10 | $9.76M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.71M 10-Q · filed 2021-09-09 | $5.59M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |